Deficits in visual sustained attention differentiate genetic liability and disease expression for Schizophrenia from Bipolar Disorder

C. Kumar,T. Christodoulou,N. Vyas,M. Kyriakopoulos,M. Kyriakopoulos,R. Corrigall,A. Reichenberg,S. Frangou

DOI: https://doi.org/10.1016/j.schres.2010.07.006

IF: 4.662

2010-12-01

Schizophrenia Research

Abstract:

What problem does this paper attempt to address?

Evolving spectrum of diabetic wound: Mechanistic insights and therapeutic targets

Raja Chakraborty,Pobitra Borah,Partha Pratim Dutta,Saikat Sen

DOI: https://doi.org/10.4239/wjd.v13.i9.696

2022-09-09

World Journal of Diabetes

Abstract:Diabetes mellitus is a chronic metabolic disorder resulting in an increased blood glucose level and prolonged hyperglycemia, causes long term health conse-quences. Chronic wound is frequently occurring in diabetes patients due to compromised wound healing capability. Management of wounds in diabetic patients remains a clinical challenge despite many advancements in the field of science and technology. Increasing evidence indicates that alteration of the biochemical milieu resulting from alteration in inflammatory cytokines and matrix metalloproteinase, decrease in fibroblast and keratinocyte functioning, neuropathy, altered leukocyte functioning, infection, etc. , plays a significant role in impaired wound healing in diabetic people. Apart from the current pharmacotherapy, different other approaches like the use of conventional drugs, antidiabetic medication, antibiotics, debridement, offloading, platelet-rich plasma, growth factor, oxygen therapy, negative pressure wound therapy, low-level laser, extracorporeal shock wave bioengineered substitute can be considered in the management of diabetic wounds. Drugs/therapeutic strategy that induce angiogenesis and collagen synthesis, inhibition of MMPs, reduction of oxidative stress, controlling hyperglycemia, increase growth factors, regulate inflammatory cytokines, cause NO induction, induce fibroblast and keratinocyte proliferation, control microbial infections are considered important in controlling diabetic wound. Further, medicinal plants and/or phytoconstituents also offer a viable alternative in the treatment of diabetic wound. The focus of the present review is to highlight the molecular and cellular mechanisms, and discuss the drug targets and treatment strategies involved in the diabetic wound. Key Words: Diabetic Wound, Diabetic Foot Ulcer, Epigenetic mechanisms, Therapeutic agents, Molecular Targets, Phytoconstituents Core Tip: This paper reviewed molecular pathways and epigenetic mechanisms involved in the pathogenesis of diabetic wounds. The role of microbiota, oxidative stress, inflammatory cytokines, and alteration in the factors involved in normal wound healing process was highlighted. Molecular targets of therapeutic agents, the role of phytochemicals was discussed. The efficacy of several pharmacotherapy, treatment strategies, and recent clinical trials aiming to improve the outcome of diabetic foot ulcers was reviewed. Citation: Chakraborty R, Borah P, Dutta PP, Sen S. Evolving spectrum of diabetic wound: Mechanistic insights and therapeutic targets. World J Diabetes 2022; 13(9): 696-716 URL: https://www.wjgnet.com/1948-9358/full/v13/i9/696.htm DOI: https://dx.doi.org/10.4239/wjd.v13.i9.696

endocrinology & metabolism
Insights into the mechanisms of diabetic wounds: pathophysiology, molecular targets, and treatment strategies through conventional and alternative therapies

Jagat Pal Yadav,Ankit Kumar Singh,Maria Grishina,Prateek Pathak,Amita Verma,Vikas Kumar,Pradeep Kumar,Dinesh Kumar Patel

DOI: https://doi.org/10.1007/s10787-023-01407-6

2024-01-13

Inflammopharmacology

Abstract:Diabetes mellitus is a prevalent cause of mortality worldwide and can lead to several secondary issues, including DWs, which are caused by hyperglycemia, diabetic neuropathy, anemia, and ischemia. Roughly 15% of diabetic patient's experience complications related to DWs, with 25% at risk of lower limb amputations. A conventional management protocol is currently used for treating diabetic foot syndrome, which involves therapy using various substances, such as bFGF, pDGF, VEGF, EGF, IGF-I, TGF-β, skin substitutes, cytokine stimulators, cytokine inhibitors, MMPs inhibitors, gene and stem cell therapies, ECM, and angiogenesis stimulators. The protocol also includes wound cleaning, laser therapy, antibiotics, skin substitutes, HOTC therapy, and removing dead tissue. It has been observed that treatment with numerous plants and their active constituents, including Globularia Arabica, Rhus coriaria L., Neolamarckia cadamba, Olea europaea, Salvia kronenburgii, Moringa oleifera, Syzygium aromaticum, Combretum molle, and Myrtus communis, has been found to promote wound healing, reduce inflammation, stimulate angiogenesis, and cytokines production, increase growth factors production, promote keratinocyte production, and encourage fibroblast proliferation. These therapies may also reduce the need for amputations. However, there is still limited information on how to prevent and manage DWs, and further research is needed to fully understand the role of alternative treatments in managing complications of DWs. The conventional management protocol for treating diabetic foot syndrome can be expensive and may cause adverse side effects. Alternative therapies, such as medicinal plants and green synthesis of nano-formulations, may provide efficient and affordable treatments for DWs.

immunology,toxicology
Healing the Diabetic Wound: Unlocking the Secrets of Genes and Pathways

Raj Kamal,Ankit Awasthi,Mandeep Pundir,Shubham Thakur

DOI: https://doi.org/10.1016/j.ejphar.2024.176645

IF: 5.195

2024-05-17

European Journal of Pharmacology

Abstract:Diabetic wounds (DWs) are open sores that can occur anywhere on a diabetic patient's body. They are often complicated by infections, hypoxia, oxidative stress, hyperglycemia, and reduced growth factors and nucleic acids. The healing process involves four phases: homeostasis, inflammation, proliferation, and remodeling, regulated by various cellular and molecular events. Numerous genes and signaling pathways such as VEGF, TGF-β, NF-κB, PPAR-γ, MMPs, IGF, FGF, PDGF, EGF, NOX, TLR, JAK-STAT, PI3K-Akt, MAPK, ERK, JNK, p38, Wnt/β-catenin, Hedgehog, Notch, Hippo, FAK, Integrin, and Src pathways are involved in these events. These pathways and genes are often dysregulated in DWs leading to impaired healing. The present review sheds light on the pathogenesis, healing process, signaling pathways, and genes involved in DW. Further, various therapeutic strategies that target these pathways and genes via nanotechnology are also discussed. Additionally, clinical trials on DW related to gene therapy are also covered in the present review.

pharmacology & pharmacy
Advances in nucleic acid delivery strategies for diabetic wound therapy

Soniya Sarthi,Harish Bhardwaj,Rajendra Kumar Jangde

DOI: https://doi.org/10.1016/j.jcte.2024.100366

2024-08-30

Abstract:In recent years, the prevalence of diabetic wounds has significantly increased, posing a substantial medical challenge due to their propensity for infection and delayed healing. These wounds not only increase mortality rates but also lead to amputations and severe mobility issues. To address this, advancements in bioactive molecules such as genes, growth factors, proteins, peptides, stem cells, and exosomes into targeted gene therapies have emerged as a preferred strategy among researchers. Additionally, the integration of photothermal therapy (PTT), nucleic acid, and gene therapy, along with 3D printing technology and the layer-by-layer (LBL) self-assembly approach, shows promise in diabetic wound treatment. Effective delivery of small interfering RNA (siRNA) relies on gene vectors. This review provides an in-depth exploration of the pathophysiological characteristics observed in diabetic wounds, encompassing diminished angiogenesis, heightened levels of reactive oxygen species, and impaired immune function. It further examines advancements in nucleic acid delivery, targeted gene therapy, advanced drug delivery systems, layer-by-layer (LBL) techniques, negative pressure wound therapy (NPWT), 3D printing, hyperbaric oxygen therapy, and ongoing clinical trials. Through the integration of recent research insights, this review presents innovative strategies aimed at augmenting the multifaceted management of diabetic wounds, thus paving the way for enhanced therapeutic outcomes in the future.
Greener healing: sustainable nanotechnology for advanced wound care

Deepinder Sharda,Komal Attri,Diptiman Choudhury

DOI: https://doi.org/10.1186/s11671-024-04061-1

2024-08-13

Abstract:Wound healing involves a carefully regulated sequence of events, encompassing pro-inflammatory and anti-inflammatory stages, tissue regeneration, and remodeling. However, in individuals with diabetes, this process gets disrupted due to dysregulation caused by elevated glucose levels and pro-inflammatory cytokines in the bloodstream. Consequently, the pro-inflammatory stage is prolonged, while the anti-inflammatory phase is delayed, leading to impaired tissue regeneration and remodeling with extended healing time. Furthermore, the increased glucose levels in open wounds create an environment conducive to microbial growth and tissue sepsis, which can escalate to the point of limb amputation. Managing diabetic wounds requires meticulous care and monitoring due to the lack of widely available preventative and therapeutic measures. Existing clinical interventions have limitations, such as slow recovery rates, high costs, and inefficient drug delivery methods. Therefore, exploring alternative avenues to develop effective wound-healing treatments is essential. Nature offers a vast array of resources in the form of secondary metabolites, notably polyphenols, known for their antimicrobial, anti-inflammatory, antioxidant, glucose-regulating, and cell growth-promoting properties. Additionally, nanoparticles synthesized through environmentally friendly methods hold promise for wound healing applications in diabetic and non-diabetic conditions. This review provides a comprehensive discussion and summary of the potential wound-healing abilities of specific natural polyphenols and their nanoparticles. It explores the mechanisms of action underlying their efficacy and presents effective formulations for promoting wound-healing activity.
Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes

S. Nirenjen,J. Narayanan,T. Tamilanban,Vetriselvan Subramaniyan,V. Chitra,Neeraj Kumar Fuloria,Ling Shing Wong,Gobinath Ramachawolran,Mahendran Sekar,Gaurav Gupta,Shivkanya Fuloria,Suresh V. Chinni,Siddharthan Selvaraj,Suresh V. Chinni

DOI: https://doi.org/10.3389/fimmu.2023.1216321

IF: 7.3

2023-07-28

Frontiers in Immunology

Abstract:Background: Impaired wound healing is the most common and significant complication of Diabetes. While most other complications of Diabetes have better treatment options, diabetic wounds remain a burden as they can cause pain and suffering in patients. Wound closure and repair are orchestrated by a sequence of events aided by the release of pro-inflammatory cytokines, which are dysregulated in cases of Diabetes, making the wound environment unfavorable for healing and delaying the wound healing processes. This concise review provides an overview of the dysregulation of pro-inflammatory cytokines and offers insights into better therapeutic outcomes. Purpose of review: Although many therapeutic approaches have been lined up nowadays to treat Diabetes, there are no proper treatment modalities proposed yet in treating diabetic wounds due to the lack of understanding about the role of inflammatory mediators, especially Pro-inflammatory mediators- Cytokines, in the process of Wound healing which we mainly focus on this review. Recent findings: Although complications of Diabetes mellitus are most reported after years of diagnosis, the most severe critical complication is impaired Wound Healing among Diabetes patients. Even though Trauma, Peripheral Artery Disease, and Peripheral Neuropathy are the leading triggering factors for the development of ulcerations, the most significant issue contributing to the development of complicated cutaneous wounds is wound healing impairment. It may even end up with amputation. Newer therapeutic approaches such as incorporating the additives in the present dressing materials, which include antimicrobial molecules and immunomodulatory cytokines is of better therapeutic value. Summary: The adoption of these technologies and the establishment of novel therapeutic interventions is difficult since there is a gap in terms of a complete understanding of the pathophysiological mechanisms at the cellular and molecular level and the lack of data in terms of the assessment of safety and bioavailability differences in the individuals' patients. The target-specific pro-inflammatory cytokines-based therapies, either by upregulation or downregulation of them, will be helpful in the wound healing process and thereby enhances the Quality of life in patients, which is the goal of drug therapy.

immunology
Effect of Diabetes on Wound Healing: A Bibliometrics and Visual Analysis

Xiaona Lang,Lu Li,Yuntao Li,Xin Feng

DOI: https://doi.org/10.2147/jmdh.s457498

2024-03-20

Journal of Multidisciplinary Healthcare

Abstract:Xiaona Lang, 1 Lu Li, 1 Yuntao Li, 2 Xin Feng 1 1 Pharmacy Department, Tianjin Hospital, Tianjin, People's Republic of China; 2 Integrative Chinese and Western Medicine Department, Tianjin Hospital, Tianjin, People's Republic of China Correspondence: Xin Feng, Pharmacy Department, Tianjin Hospital, Tianjin, People's Republic of China, Tel +86-13652001152, Email Objective: The quality of life of diabetic patients is seriously affected by wound healing difficulty, which can lead to increased infection, skin deep tissue injury and continuous pain. By analyzing the research trends and hot spots in this field, the visualization analysis map is constructed. Methods: The contents of the selected articles were sorted out and analyzed by bibliometrics. We use CiteSpace, Vosviewer and HistCite to visualize literature information, including national publication statistics, institutions, authors, journal partnerships, and citations of published articles. Results: Among the 2942 articles, the United States and China ranked first in both article circulation and TGCS, and many countries also cooperated. The collaboration between schools and research institutions is a core part of dissertation research institution collaboration, with most authors coming from the same institution. Most of the literature studies on the mechanisms and methods of promoting diabetic wound healing. Improving cell function or making innovative attempts in local treatment are the fruits of researchers' efforts to promote diabetic wound healing in recent years. Conclusion: Through the metrology method, the time distribution, author institution, cooperation network, research status, research hotspot and development trend of the literature on the influence of diabetes on wound healing were intuitively displayed, which provided a reference for further research and development direction. Keywords: diabetes, wound healing, bibliometrics, visualized analysis, Citespace Diabetes, a prevalent chronic metabolic disorder, poses an increasing global health threat. The World Health Organization reports that a significant number of individuals worldwide are afflicted with diabetes, a number that continues to rise. 1 In addition to elevated blood glucose levels, insulin resistance, and associated complications, impaired wound healing presents a significant challenge for individuals with diabetes. 2 Recent years have witnessed notable progress in strategies to improve wound healing in diabetic patients, encompassing novel pharmacological interventions, state-of-the-art wound care technologies, and innovative approaches to glycemic control and infection management. However, the field is marked by rapid evolution and a constant influx of novel methodologies and technologies, emphasizing the necessity of regularly reviewing and integrating the extensive array of emerging data. Wound healing refers to the process by which wounds return to their normal state with the support of a series of biological processes after injury. 2–4 However, diabetic wounds are skin and tissue damage caused by prolonged high blood sugar. If left untreated and unmanaged, diabetic ulcers can lead to the following consequences. 1. Infection: Due to the weak immune function of diabetic patients, ulcers are easily infected, and infection will further delay the healing rate of ulcers. Severe infections can spread to surrounding tissues and bones, threatening the health of the body. Severe cases can even lead to gangrene: When the tissue in the ulcer is severely infected, and the blood supply is insufficient, tissue necrosis may occur, forming gangrene. Gangrene severely threatens surrounding tissues and organs and requires urgent treatment, including surgical removal of dead tissue. 5,6 2. Deep tissue damage: Diabetic ulcers usually occur in the foot and may cause damage to the deep tissues of the foot, such as muscles, ligaments, and bones, due to neuropathy and circulation problems. This can lead to joint stiffness, muscle dysfunction, and even fractures. 7,8 3. Chronic pain: Diabetic ulcers may cause persistent pain that affects the patient's quality of life and daily activities. Chronic pain can hurt emotional and mental health. 4,9,10 Given the rapidly evolving landscape of wound healing strategies in diabetes care, there is an urgent requirement for a comprehensive analysis that comprehensively delineates the current state of research. A bibliometric analysis provides a systematic method to chart the course of these developments, discern predominant trends, and underscore areas necessitating additional exploration. Such an analysis plays a pivotal role in offering a complete perspectiv -Abstract Truncated-

health care sciences & services
Deciphering Diabetic Foot Wounds: A Comprehensive Review on Classification, Multidrug Resistance, Microbial Insights, Management & Treatment Strategies, and Advanced Diagnostic Tools

Susan Silvia N,Mahalakshmi Velrajan

DOI: https://doi.org/10.2174/0115733998287694240514110935

2024-05-24

Abstract:Diabetic foot wounds and infections pose a significant and evolving challenge in diabetes care. Diabetic wound healing has become a major global concern for a very long time. Continuous research has been conducted to increase the healing process in diabetic ulcers to the rate of amputation. Wound healing is prolonged in diabetic patients due to various conditions, such as high glucose levels, neuropathy, poor blood circulation, and prolonged inflammation around the limbs, which causes the healing to be delayed compared to normal patients. Understanding the complexity of chronic foot wounds and the management and proper treatment would lead to a decrease in the risk of amputation. The medical team all over the world is constantly researching to lower the risk. This review paper offers a compelling journey through the multifaceted world of diabetic foot wounds and infections. It underscores the urgency of understanding classification, tackling multidrug resistance, and harnessing microbial insights to revolutionize the treatment and management of diabetic foot complications. Furthermore, it unveils state-of-the-art diagnostics, heralding a brighter future in the battle against this debilitating complication of diabetes.
Inflammation-Modulating Biomedical Interventions for Diabetic Wound Healing: An Overview of Preclinical and Clinical Studies

Nouf N Mahmoud,Salma Hamad,Sawsan Shraim

DOI: https://doi.org/10.1021/acsomega.4c02251

IF: 4.1

2024-11-01

ACS Omega

Abstract:A diabetic wound exemplifies the challenge of chronic, nonhealing wounds. Elevated blood sugar levels in diabetes profoundly disrupt macrophage function, impairing crucial activities such as phagocytosis, immune response, cell migration, and blood vessel formation, all essential for effective wound healing. Moreover, the persistent presence of pro-inflammatory cytokines and reactive oxygen species, coupled with a decrease in anti-inflammatory factors, exacerbates the delay in wound healing associated with diabetes. This review emphasizes the dysfunctional inflammatory responses underlying diabetic wounds and explores preclinical studies of inflammation-modulating bioactives and biomaterials that show promise in expediting diabetic wound healing. Additionally, this review provides an overview of selected clinical studies employing biomaterials and bioactive molecules, shedding light on the gap between extensive preclinical research and limited clinical studies in this field.
Mechanobiology of diabetes and its complications

Chenyu Huang,Rei Ogawa

DOI: https://doi.org/10.1016/b978-0-12-821070-3.00011-8

2021-01-01

Abstract:Diabetes mellitus and its complications have long been severe problems on a global scale. Diabetic wounds in particular significantly decrease patient quality of life. While much is known about diabetes at a biochemical level (e.g., the role of blood glucose), there is currently little awareness about the mechanobiology that participates in the evolution and progression of this disease. Here, we will discuss the mechanobiology of diabetic wounds. Thus, the mechanobiological changes that accompany diabetes at the macro, cellular, and molecular levels will be described along with two effective mechanotherapeutic interventions for diabetic wounds, namely, negative pressure wound therapy and extracorporeal shock wave therapy. The mechanisms that underlie these therapies will also be discussed. It is likely that a better understanding of the mechanobiology of and mechanotherapies for diabetes and its complications will aid the development of novel interventions that could ultimately prevent, reduce, or reverse diabetes and its complications.
Current Therapeutic Modalities for the Management of Chronic Diabetic Wounds of the Foot

Olajumoke Arinola Oyebode,Sandy Winfield Jere,Nicolette Nadene Houreld

DOI: https://doi.org/10.1155/2023/1359537

IF: 4.0608

2023-02-12

Journal of Diabetes Research

Abstract:Impaired wound healing is common in patients with diabetes mellitus (DM). Different therapeutic modalities including wound debridement and dressing, transcutaneous electrical nerve stimulation (TENS), nanomedicine, shockwave therapy, hyperbaric (HBOT) and topical (TOT) oxygen therapy, and photobiomodulation (PBM) have been used in the management of chronic diabetic foot ulcers (DFUs). The selection of a suitable treatment method for DFUs depends on the hosts' physiological status including the intricacy and wound type. Effective wound care is considered a critical component of chronic diabetic wound management. This review discusses the causes of diabetic wounds and current therapeutic modalities for the management of DFUs, specifically wound debridement and dressing, TENS, nanomedicine, shockwave therapy, HBOT, TOT, and PBM.

endocrinology & metabolism,medicine, research & experimental
Nanoparticles for Delivering Micro and Macromolecules for the Management of Diabetic Wounds

Vidyasrilekha Sanapalli,Md Azizul Haque,Bharat Kumar Reddy Sanapalli,Veera Venkata Satyanarayana Reddy Karri,Tonmoy Kumar Mondal,Paritosh Barai,Md. Rabiul Islam,Farha Farahim,Talat Ali,Hasi Rani Barai,Madhusudan Roy

DOI: https://doi.org/10.1002/cbf.70006

2024-11-07

Cell Biochemistry and Function

Abstract:Diabetes mellitus (DM) is a chronic metabolic disorder that affects most vital organs in the body. Approximately 463 million people were diagnosed with DM worldwide in 2019. The incidence of DM is estimated to increase by 700 million by 2045. Diabetic wounds (DWs) are among the most severe complications in people suffering from DM. Although diverse standard care treatment strategies are available for DWs, they are unsatisfactory because of the multifactorial pathophysiology of DWs. Cutting‐edge nanoparticles are increasingly being used in treating DWs. In particular, few nanoparticles naturally act as ROS scavengers, promote angiogenesis, exhibit antimicrobial activity, and form the extracellular matrix, which is considered beneficial for DW healing. The current review focused on the pivotal potential of the present nanoparticles for DW healing, emphasizing and highlighting the use of the nanoparticles in delivering micro and macromolecules in tissue regeneration for DW healing and future perspectives.

cell biology,biochemistry & molecular biology
Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcers (DFU), current therapeutic strategies and future directions

Fatima Mohsin,Sheza Javaid,Mishal Tariq,Muhammad Mustafa

DOI: https://doi.org/10.1016/j.intimp.2024.112713

2024-09-30

Abstract:Diabetic foot ulcer (DFU) is a foremost cause of amputation in diabetic patients. Consequences of DFU include infections, decline in limb function, hospitalization, amputation, and in severe cases, death. Immune cells including macrophages, regulatory T cells, fibroblasts and other damage repair cells work in sync for effective healing and in establishment of a healthy skin barrier post-injury. Immune dysregulation during the healing of wounds can result in wound chronicity. Hyperglycemic conditions in diabetic patients influence the pathophysiology of wounds by disrupting the immune system as well as promoting neuropathy and ischemic conditions, making them difficult to heal. Chronic wound microenvironment is characterized by increased expression of matrix metalloproteinases, reactive oxygen species as well as pro-inflammatory cytokines, resulting in persistent inflammation and delayed healing. Novel treatment modalities including growth factor therapies, nano formulations, microRNA based treatments and skin grafting approaches have significantly augmented treatment efficiency, demonstrating creditable efficacy in clinical practices. Advancements in local treatments as well as invasive methodologies, for instance formulated wound dressings, stem cell applications and immunomodulatory therapies have been successful in targeting the complex pathophysiology of chronic wounds. This review focuses on elucidating the intricacies of emerging physical and non-physical therapeutic interventions, delving into the realm of advanced wound care and comprehensively summarizing efficacy of evidence-based therapies for DFU currently available.
Novel Biotherapeutics Targeting Biomolecular and Cellular Approaches in Diabetic Wound Healing

Suraj Kumar Singh,Shradha Devi Dwivedi,Krishna Yadav,Kamal Shah,Nagendra Singh Chauhan,Madhulika Pradhan,Manju Rawat Singh,Deependra Singh

DOI: https://doi.org/10.3390/biomedicines11020613

IF: 4.757

2023-02-19

Biomedicines

Abstract:Wound healing responses play a major role in chronic inflammation, which affects millions of people around the world. One of the daunting tasks of creating a wound-healing drug is finding equilibrium in the inflammatory cascade. In this study, the molecular and cellular mechanisms to regulate wound healing are explained, and recent research is addressed that demonstrates the molecular and cellular events during diabetic wound healing. Moreover, a range of factors or agents that facilitate wound healing have also been investigated as possible targets for successful treatment. It also summarises the various advances in research findings that have revealed promising molecular targets in the fields of therapy and diagnosis of cellular physiology and pathology of wound healing, such as neuropeptides, substance P, T cell immune response cDNA 7, miRNA, and treprostinil growth factors such as fibroblast growth factor, including thymosin beta 4, and immunomodulators as major therapeutic targets.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Brandon J Sumpio,Ikram Mezghani,Enya Wang,Zhuqing Li,Eleftheria-Angeliki Valsami,Georgios Theocharidis,Aristidis Veves

DOI: https://doi.org/10.1080/13543784.2023.2178418

2023-02-23

Expert Opinion on Investigational Drugs

Abstract:Diabetes affects 400 million people globally and patients and causes nephropathy, neuropathy, and vascular disease. Amongst these complications, diabetic foot ulcers remain a substantial problem for patients and clinicians. Aggressive wound care and antibiotics remain important for the healing of these chronic wounds, but even when treated these chronic ulcers can lead to infection and amputations This paper reviews the pathophysiology of diabetic foot ulcers and the current management strategies. Then, it discusses novel therapeutics such as topical oxygen therapy as well as autologous patches and macrophage creams. Diabetic foot ulcers are a substantial problem for patients and clinicians. Early identification, aggressive wound care, and normoglycemia remain the standard of care, however when these fail it is important to adapt. Since each patient and wound vary drastically we believe they should be treated as such. For patient with intact perfusion, topical ON101 and sucrose octasulfate creams can help. While patient with peripheral arterial disease should consider topical oxygen therapy as an adjunct. However, as scientists gain a better understanding of the pathophysiology behind DFUs, the hope is that this new wave of therapeutics will emerge.

pharmacology & pharmacy
Materials and Cytokines in the Healing of Diabetic Foot Ulcers

KaKyung Kim,Aryan Mahajan,Kamiya Patel,Shareef Syed,Amanda M. Acevedo‐Jake,Vivek A. Kumar

DOI: https://doi.org/10.1002/adtp.202100075

IF: 5.003

2021-07-02

Advanced Therapeutics

Abstract:Diabetes affects an increasing number of patients, and is associated with sustained and chronic inflammation. Complications arising from diabetes, including hypoxia, neuropathy, hyperglycemia, and ischemia that contribute to a delayed and reduced healing response result in chronic slow healing wounds. Here, key differences in native versus diabetic wound healing during each phase of healing are discussed, and the roles of cells and their secreted cytokines which regulate this process are outlined. Monocyte chemoattractant protein‐1 (MCP‐1) is a pro‐inflammatory mediator which plays a key role in modulating angiogenesis. Its importance in diabetic wound healing as well as recent work using MCP‐1 and similar chemokines to reduce inflammation and improve healing are reviewed. The delayed healing response observed in diabetic patients often results in the formation of slow healing wounds, commonly presenting in the lower extremities as diabetic foot ulcers (DFUs); classification systems and current treatment options for DFUs, including debridement, off‐loading, and amputation are outlined. Common dressing strategies are highlighted, and recent work developing biocompatible and bioactive hydrogels to address and hasten chronic wound healing is focused on. Diabetic patients face an altered wound healing mechanism which results in the formation of chronic, slow healing wounds such as diabetic foot ulcers. Current and developing treatment options include debridement, off‐loading, and dressings such as hydrocolloids, film, alginates, and bioactive hydrogels. Hydrogels, in particular, are tunable, readily formulated, and easily delivered to combat associated infection, ischemia, scarring, and inflammation.

English Else
Smart Wound Dressings for Diabetic Chronic Wounds

Elizabeth Gianino,Craig Miller,Jordon Gilmore

DOI: https://doi.org/10.3390/bioengineering5030051

IF: 5.046

2018-06-26

Bioengineering

Abstract:Given their severity and non-healing nature, diabetic chronic wounds are a significant concern to the 30.3 million Americans diagnosed with diabetes mellitus (2015). Peripheral arterial diseases, neuropathy, and infection contribute to the development of these wounds, which lead to an increased incidence of lower extremity amputations. Early recognition, debridement, offloading, and controlling infection are imperative for timely treatment. However, wound characterization and treatment are highly subjective and based largely on the experience of the treating clinician. Many wound dressings have been designed to address particular clinical presentations, but a prescriptive method is lacking for identifying the particular state of chronic, non-healing wounds. The authors suggest that recent developments in wound dressings and biosensing may allow for the quantitative, real-time representation of the wound environment, including exudate levels, pathogen concentrations, and tissue regeneration. Development of such sensing capability could enable more strategic, personalized care at the onset of ulceration and limit the infection leading to amputation. This review presents an overview of the pathophysiology of diabetic chronic wounds, a brief summary of biomaterial wound dressing treatment options, and biosensor development for biomarker sensing in the wound environment.

English Else
Unlocking the potential of flavonoid-infused drug delivery systems for diabetic wound healing with a mechanistic exploration

Ankit Chowdhury,Papiya Mitra Mazumder

DOI: https://doi.org/10.1007/s10787-024-01561-5

2024-09-03

Inflammopharmacology

Abstract:Diabetes is one of the common endocrine disorders generally characterized by elevated levels of blood sugar. It can originate either from the inability of the pancreas to synthesize insulin, which is considered as an autoimmune disorder, or the reduced production of insulin, considered as insulin resistivity. A wound can be defined as a condition of damage to living tissues including skin, mucous membrane and other organs as well. Wounds get complicated with respect to time based on specific processes like diabetes mellitus, obesity and immunocompromised conditions. Proper growth and functionality of the epidermis gets sustained due to impaired diabetic wound healing which shows a sign of dysregulated wound healing process. In comparison with synthetic medications, phytochemicals like flavonoids, tannins, alkaloids and glycosides have gained enormous importance relying on their distinct potential to heal diabetic wounds. Flavonoids are one of the most promising and important groups of natural compounds which can be used to treat acute as well as chronic wounds. Flavonoids show excellent properties due to the presence of hydroxyl groups in their chemical structure, which makes this class of compounds different from others. Based on the novel principles of nanotechnology via utilizing suitable drug delivery systems, the delivery of bioactive constituents from plant source amplifies the wound-healing mechanism, minimizes complexities and enhances bioavailability. Hence, the encapsulation and applicability of flavonoids with an emphasis on mechanistic route and wound-healing therapeutics have been highlighted in the subsequent study with focus on multiple drug delivery systems.

immunology,toxicology
Managing drug therapy-related problems and assessment of chronic diabetic wounds

Maria Infant Majula Shifani Mahendran,Vinoj Gopalakrishnan,Vaijayanthi Saravanan,Ramasamy Dhamodharan,Pradeep Jothimani,M. Balasubramanian,Abhimanyu Kumar Singh,Rajan Vaithianathan

DOI: https://doi.org/10.1080/03007995.2024.2414893

2024-11-02

Current Medical Research and Opinion

Abstract:Type 2 diabetes mellitus (T2DM), responsible for most diabetes cases recorded worldwide, increases the risk of chronic wounds and amputation. Patients with T2DM appear to be more susceptible to delayed wound healing due to their treatment adherence. This review explores the specifics of polypharmacy, side effects, possible drug interactions and the importance of medication adherence for therapeutic efficacy. We discuss the effects of anti-diabetes medications on wound healing as well as the role that biofilms and microbial infections play in diabetic wounds. Inconsistent use of medications can lead to poor glycaemic control, which negatively affects the healing process of diabetic foot ulcers. Managing chronic wounds represents a substantial portion of healthcare expenditures. Biofilm-associated infections are difficult for the immune system to treat and respond inconsistently to antibiotics as these infections are slow growing and persistent. Additionally, we emphasize the critical role pharmacists play in enhancing patient adherence and optimizing diabetes treatment by offering comprehensive coverage of drugs associated with problems related to pharmacological therapy in type 2 diabetes.

medicine, general & internal, research & experimental
Natural Flavonoids as Potential Therapeutics in the Management of Diabetic Wound: A Review

Nongmaithem Randhoni Chanu,Pal Gogoi,Pervej Alom Barbhuiya,Partha Pratim Dutta,Manash Pratim Pathak,Saikat Sen

DOI: https://doi.org/10.2174/1568026623666230419102140

Abstract:Flavonoids are important bioactive phenolic compounds abundant in plants and exhibit different therapeutic potentials. A wound is a significant problem in diabetic individuals. A hyperglycaemic environment alters the normal wound-healing process and increases the risk of microbial infection, leading to hospitalization, morbidity, and amputation. Flavonoids are an important class of phytochemicals with excellent antioxidant, anti-inflammatory, antimicrobial, antidiabetic, antitumor, and wound healing property. Quercetin, hesperidin, curcumin, kaempferol, apigenin, luteolin, morin, etc. have shown their wound healing potential. Flavonoids effectively exhibit antimicrobial activity, scavenge reactive oxygen species, augment endogenous antioxidants, reduce the expression and synthesis of inflammatory cytokines (i.e. IL-1β, IL-6, TNF-α, NF-κB), inhibit inflammatory enzymes, enhance anti-inflammatory cytokine (IL-10), enhance insulin section, reduce insulin resistance, and control blood glucose level. Several flavonoids like hesperidin, curcumin, quercetin, rutin, naringin, and luteolin have shown their potential in managing diabetic wounds. Natural products that maintain glucose haemostatic, exert anti-inflammatory activity, suppress/inhibit microbial growth, modulate cytokines, inhibit matrix metalloproteinase (MMP), stimulate angiogenesis and extracellular matrix, and modulate growth factor can be considered as a potential therapeutic lead to treat diabetic wound. Flavonoids were found to play a positive role in management of diabetic wounds by regulating MMP-2, MMP-8, MMP-9, MMP-13, Ras/Raf/ MEK/ERK, PI3K/Akt, and nitric oxide pathways. Therefore, it can be assumed that flavonoids could be potential therapeutics to prevent devastating effects of diabetic wounds. This paper focused on the potential role of flavonoids in managing diabetic wounds and discussed their possible mechanism of action.

Deficits in visual sustained attention differentiate genetic liability and disease expression for Schizophrenia from Bipolar Disorder

Evolving spectrum of diabetic wound: Mechanistic insights and therapeutic targets

Insights into the mechanisms of diabetic wounds: pathophysiology, molecular targets, and treatment strategies through conventional and alternative therapies

Healing the Diabetic Wound: Unlocking the Secrets of Genes and Pathways

Advances in nucleic acid delivery strategies for diabetic wound therapy

Greener healing: sustainable nanotechnology for advanced wound care

Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes

Effect of Diabetes on Wound Healing: A Bibliometrics and Visual Analysis

Deciphering Diabetic Foot Wounds: A Comprehensive Review on Classification, Multidrug Resistance, Microbial Insights, Management & Treatment Strategies, and Advanced Diagnostic Tools

Inflammation-Modulating Biomedical Interventions for Diabetic Wound Healing: An Overview of Preclinical and Clinical Studies

Mechanobiology of diabetes and its complications

Current Therapeutic Modalities for the Management of Chronic Diabetic Wounds of the Foot

Nanoparticles for Delivering Micro and Macromolecules for the Management of Diabetic Wounds

Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcers (DFU), current therapeutic strategies and future directions

Novel Biotherapeutics Targeting Biomolecular and Cellular Approaches in Diabetic Wound Healing

Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Materials and Cytokines in the Healing of Diabetic Foot Ulcers

Smart Wound Dressings for Diabetic Chronic Wounds

Unlocking the potential of flavonoid-infused drug delivery systems for diabetic wound healing with a mechanistic exploration

Managing drug therapy-related problems and assessment of chronic diabetic wounds

Natural Flavonoids as Potential Therapeutics in the Management of Diabetic Wound: A Review